News

8 June 2015, Liège, FDA approved Sotalol IV 

Sotalol IV (sotalol hydrochloride injection 15mg/mL for intravenous use) was launched in the United States by Hyloris Pharmaceuticals partner Altathera Pharmaceuticals in June 2015. Continue Reading

 

Comments are closed